Evidence map›Paper›PMID 24979131›Full record

ArticleInternational journal of molecular sciences2014

Biochemical alterations during the obese-aging process in female and male monosodium glutamate (MSG)-treated mice.

René J Hernández-Bautista, Francisco J Alarcón-Aguilar, María Del C Escobar-Villanueva, Julio C Almanza-Pérez, Héctor Merino-Aguilar, Mina Konigsberg Fainstein, Norma E López-Diazguerrero

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Effects ofMolecules (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Hepatic FGF21 Deletion Improves Glucose Metabolism, Alters Lipogenic andInternational journal of molecular sciences · 2025
    Article
  5. Monosodium glutamate: A hidden risk factor for obesity?Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Review
  6. The role of fatty acid metabolism on B cells and B cell-related autoimmune diseases.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Rutin andFrontiers in veterinary science · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

René J Hernández-BautistaPost-Grade in Experimental Biology, Division of Health and Biological Sciences, Metropolitan Autonomous University, A.P. 55-535, D.F. Mexico, Mexico. mkf@xanum.uam.mx.
Francisco J Alarcón-AguilarLaboratory of Pharmacology, Department of Health Sciences, Division of Health and Biological Sciences, Metropolitan Autonomous University, A.P. 55-535, D.F. Mexico, Mexico. aaaf@xanum.uam.mx.
María Del C Escobar-VillanuevaLaboratory of Pharmacology, Department of Health Sciences, Division of Health and Biological Sciences, Metropolitan Autonomous University, A.P. 55-535, D.F. Mexico, Mexico. mcev@xanum.uam.mx.
Julio C Almanza-PérezLaboratory of Pharmacology, Department of Health Sciences, Division of Health and Biological Sciences, Metropolitan Autonomous University, A.P. 55-535, D.F. Mexico, Mexico. jcap@xanum.uam.mx.
Héctor Merino-AguilarLaboratory of Pharmacology, Department of Health Sciences, Division of Health and Biological Sciences, Metropolitan Autonomous University, A.P. 55-535, D.F. Mexico, Mexico. mkf@xanum.uam.mx.
Mina Konigsberg FainsteinLaboratory of Bioenergetics and Cellular Aging, Department of Health Sciences, Division of Health and Biological Sciences, Metropolitan Autonomous University, A.P. 55-535, D.F. Mexico, Mexico. mkf@xanum.uam.mx.
Norma E López-DiazguerreroLaboratory of Bioenergetics and Cellular Aging, Department of Health Sciences, Division of Health and Biological Sciences, Metropolitan Autonomous University, A.P. 55-535, D.F. Mexico, Mexico. norm@xanum.uam.mx.
Universidad Autónoma Metropolitana · MXBioEnergetics (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity, from children to the elderly, has increased in the world at an alarming rate over the past three decades, implying long-term detrimental consequences for individual's health. Obesity and aging are known to be risk factors for metabolic disorder development, insulin resistance and inflammation, but their relationship is not fully understood. Prevention and appropriate therapies for metabolic disorders and physical disabilities in older adults have become a major public health challenge. Hence, the aim of this study was to evaluate inflammation markers, biochemical parameters and glucose homeostasis during the obese-aging process, to understand the relationship between obesity and health span during the lifetime. In order to do this, the monosodium glutamate (MSG) obesity mice model was used, and data were evaluated at 4, 8, 12, 16 and 20 months in both female and male mice. Our results showed that obesity was a major factor contributing to premature alterations in MSG-treated mice metabolism; however, at older ages, obesity effects were attenuated and MSG-mice became more similar to normal mice. At a younger age (four months old), the Lee index, triglycerides, total cholesterol, TNF-α and transaminases levels increased; while adiponectin decreased and glucose tolerance and insulin sensitivity levels were remarkably altered. However, from 16 months old-on, the Lee index and TNF-α levels diminished significantly, while adiponectin increased, and glucose and insulin homeostasis was recovered. In summary, MSG-treated obese mice showed metabolic changes and differential susceptibility by gender throughout life and during the aging process. Understanding metabolic differences between genders during the lifespan will allow the discovery of specific preventive treatment strategies for chronic diseases and functional decline.

Indexed as

AdiponectinAge FactorsAnimalsCholesterolFemaleInterleukin-6MaleMiceObesitySex FactorsSodium GlutamateTransaminasesTriglyceridesTumor Necrosis Factor-alphaAdiponectinCholesterolInterleukin-6Sodium GlutamateTransaminasesTriglyceridesTumor Necrosis Factor-alpha

Identifiers

PMID24979131
PMCPMC4139794
OpenAlexW2064573457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.